Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL35AP6 encodes a processed pseudogene related to the ribosomal protein L35a family[4], specifically mirroring the functional RPL35A gene, which encodes a structural protein of the 60S ribosomal subunit[1][3]. Pseudogenes like RPL35AP6 do not encode functional proteins and lack known direct biological activity or established therapeutic roles[4][2]. They typically arise through gene duplication or retrotransposition events and may participate in RNA-mediated regulatory processes in rare cases, but no such function is documented for RPL35AP6 specifically. The functional RPL35A gene, but not its pseudogenes, is linked to diseases such as Diamond-Blackfan Anemia[3]. Pseudogenes can act as competitive endogenous RNAs or microRNA decoys, as demonstrated in rare cases for other genes; however, no published data supports RPL35AP6 in such a role[5]. Therefore, it is not recognized as a therapeutic, receptor, or drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal Protein L35a Pseudogene 6 (RPL35AP6).